Inhibitory effects of green tea and grape juice on the phenol sulfotransferase activity of mouse intestines and human colon carcinoma cell line, Caco-2

Biological and Pharmaceutical Bulletin

Volumn 23, Issue 6, 2000, Pages 695-699

  Tamura, Hiro Omi ^a   Matsui, Michio ^a  

^a KEIO UNIVERSITY   (Japan)

Author keywords

Caco 2; Catechin; Flavonol; Green tea; Inhibition; Sulfotransferase

Indexed keywords

ARYL SULFOTRANSFERASE; EPIGALLOCATECHIN GALLATE; FLAVONOL DERIVATIVE; INTESTINE ENZYME; KAEMPFEROL; QUERCETIN;

ANIMAL TISSUE; ARTICLE; BEVERAGE; CELL STRAIN CACO 2; COMPETITIVE INHIBITION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME KINETICS; FRUIT JUICE; GRAPE; HUMAN; HUMAN CELL; MALE; MOUSE; NONHUMAN; PLANT LEAF; PLANT SEED; TEA;

EID: 0033936402     PISSN: 09186158     EISSN: None     Source Type: Journal    
DOI: 10.1248/bpb.23.695     Document Type: Article

References (26)

1. Mulder G. J., Jakoby W. B., "Conjugation Reactions in Drug Metabolism," ed. by Mulder G. J., Taylor and Francis, London, 1990, pp. 107-161.
2. Weinshilboum R., Otterness D., "Conjugation-Deconjugation Reactions in Drug Metabolism and Toxicity," ed. by Kauffman F. C., Springer-Verlag, Berlin, 1994, pp. 45-78.
3. Matsui M., Homma H., Int. J. Biochem., 26, 1237-1247 (1994).
4. Rikke B. A., Roy A. K., Biochem. Biophys. Acta, 1307, 331-338 (1996).
5. Weinshilboum R., Otterness D., Aksoy I. A., Wood T., Her C., Raftogains R. B., FASEB J., 11, 3-14 (1997).
6. Falany C., FASEB J., 11, 206-216 (1997).
7. Tamura H., Miyawaki A., Yoneshima H., Mikoshiba K., Matsui M., Biol. Pharm. Bull., 22, 234-239 (1999).
8. Pang K. S., "Conjugation Reactions in Drug Metabolism," ed. by Mulder G. J., Taylor and Francis, London, 1990, pp. 5-39.
9. Podder S. K., Nakashima M., Nakamura T., Sasaki H., Nakamura J., Shibasaki J., J. Pharmacobio-Dyn., 9, 917-922 (1986).
10. Tone Y., Kawamata K., Murakami T., Higashi Y., Yata N., J. Pharmacobio-Dyn. 13, 327-335 (1990).
11. James M. O., Altman A. H., Morris K., Kleinow K. M., Tong Z., Drug Metab. Dispos., 25, 346-354 (1997).
12. Foldes A., Meek J. L., Biochim. Biophys. Acta, 327, 365-374 (1973).
13. Miyawaki A., Homma H., Tamura H., Matsui M., Mikoshiba K., EMBO J., 15, 2050-2055 (1996).
14. Tamura H., Miyawaki A., Inoh N., Harada Y., Mikoshiba K., Matsui M., Chem.-Biol. Interact., 104, 1-9 (1997).
15. Kuroda Y., Hara Y., Mutation Res., 436, 69-97 (1999).
16. Yang G., Liao J., Kim K., Yurkow E. J., Yang S., Carcinogenesis, 19, 611-616 (1998).
17. Seah V. M., Wong K. P., Biochem. Pharmacol., 47, 1743-1749 (1994).
18. Fogh J., Wright W. C., Loveless J. D., J. Natl. Cancer Inst., 58, 209-214 (1977).
19. Gan L.-S. L., Thakker D. R., Adv. Drug Delivery Rev., 23, 77-98 (1997).
20. Waterhouse A., Walzman R. L., "Flavonoids in Health and Disease," ed. by Rice-Evans C. A., Packer L., Marcel Dekker, New York, 1998, pp. 359-385.
21. Yamazoe Y., Abu-Zeid M., Gong D., Ataiano N., Kato R., Carcinogenesis, 10, 1675-1679 (1989).
22. Surh Y.-J., Chem.-Biol. Interact., 109, 221-235 (1998).
23. Yang C. S., Nature, 389, 134-135 (1997).
24. Nakagawa K., Okuda S., Miyazawa T., Biosci. Biotech. Biochem., 61, 1981-1985 (1997).
25. Nakagawa K., Miyazawa T., J. Nutr. Sci. Vitaminol., 43, 679-684 (1997).
26. Glatt FASEB J., 11, 314-321 (1997).